Depression is a common but serious mood disorder. It causes a variety of severe symptoms that affect all aspects of everyday life. To complicate matters, the reason people become depressed doesn’t come from one gene, one life event, or one personality trait. This ambiguity is what makes it so hard to predict, prevent or treat effectively.
Researchers have now developed a tool that uses a range of genetic information to predict a person’s chance of developing depression when they’re under intense stress. Investigators believe the findings might help lead to a better understanding of the pathways that lead to depression.
While the tool is far from ready for common use on individuals, it does suggest the potential to identify those who might be most vulnerable to stress or most resilient. This capability offers the potential to personalize depression prevention.
The study was done in a population of more than 5,200 people in the most stressful year of training for a medical career, called the intern year of residency. Researchers from the University of Michigan describe their results in the journal Nature Human Behavior.
The team used a genetic risk-assessment tool called polygenic risk score. They constructed a genetic risk score for major depressive disorder, or MDD-PRS, from widely available consortium and biobank data. The data helped researchers match the known associations between a person’s risk of depression, and variations throughout a person’s genome.
While genetics and stress are known to play a role in depression risk and onset, the new research helps reveal the way these factors interact.
The interns who had higher-than-average MDD-PRS scores were slightly more likely to be among the 3 percent of interns who showed signs of depression before their intern year started. But by the end of the year, these high PRS subjects were much more likely to be among the 33 percent of interns who had developed depression.
On the other hand, the group with the lowest MDD-PRS scores were far less likely to show signs of depression throughout their intern year, suggesting that the scoring system could be used to identify those most likely to be resilient despite intense stress.
The research team tested the predictive power of MDD-PRS on young doctors taking part in the Intern Health Study, led by Srijan Sen, M.D., Ph.D., the senior author of the new paper.
The Intern Health Study enrolls thousands of new physicians across the United States each year. Each participant agrees to let the research team sample their DNA, and to answer surveys before they begin their intern year of medical training. They are then queried several times during that intense year of long hours and high demands.
Sen and the study’s first author, U-M research specialist Yu Fang, combined data across millions of sites within the human genomes to construct a MDD-PRS calculation. They then looked to see how well a person’s “score” on this tool predicted with their scores on standard surveys of depressive symptoms.
Researchers also assessed whether the MDD-PRS worked through known mechanisms to depression, such personal and family history, childhood experience or general temperament. The result: the MDD-PRS accurately predicted the chance that certain interns would develop depression symptoms while under stress.
“Interestingly, we found evidence that the association between MDD-PRS and depression is stronger in the presence of stress and that the additional predictive power of MDD-PRS under stress is largely independent of known risk factors for depression,” said Sen.
“These findings further our understanding of how genomics and stress interact and suggest that further investigation of the genomics of stress response can uncover novel mechanisms that lead to depression.”
The major limitation of the new study has to do with the source of the genetic information it’s based on. Because most research on the genetics of depression has been done in people of European ancestry, the MDD-PRS tool used in the study is specific to people of that background.
In fact, the tool failed to predict depression symptoms among groups of interns of south Asian or east Asian background who were also taking part in the Intern Health Study.
Also, the group of interns in the study was young, with an average age of 27, and had already graduated medical school and been accepted into a residency training program, making them not representative of the general population. Despite these limitations, this test of the MDD-PRS suggests its potential use.
“We are optimistic that these findings will be transferred to other ethnic groups with improving multi-ethnic analysis techniques and more data collected from these populations,” said Fang. She also notes the predictive power of the MDD-PRS score to predict resilience is stronger than its ability to predict susceptibility.
“We hope this will ease the worry that this tool might be misused to discriminate against at-risk individuals.”
Sen, Fang and their colleagues used genetic linkages for depression identified through three major pools of DNA data: the Psychiatric Genomics Consortium, the UK Biobank and the commercial genetics company 23andMe.
Prior research has established that depression symptoms rise over the course of the intern year. Moreover, the importance of the personality trait known as neuroticism as well as of an intern’s own history of stressful childhood events or traumas, and any past diagnosis of depression have been viewed as potential risk factors.
Under low-stress conditions before intern year started, most of the genomic risk captured by MDD-PRS worked through these three established risk factors. However, while the overall predictive power of MDD-PRS increased significantly under the stress of intern year, the predictive power of the three established factors remained the same.
“This suggests that as-yet-undiscovered factors accounted for the greater link between MDD-PRS and depression under the high stress conditions, suggesting a possible pathway to learning more about those undiscovered factors,” said Sen.